Get startedLog in
    Picture of Chunghwa Chemical Synthesis & Biotech Co logo

    1762 — Chunghwa Chemical Synthesis & Biotech Co Cashflow Statement

    0.000.00%
    tw flag iconLast trade - 00:00
    HealthcareBalancedSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Chunghwa Chemical Synthesis & Biotech Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line65049858333357.2
    Depreciation
    Amortisation
    Non-Cash Items-385-31.9-73.1-36.1-17.4
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-259-37954.6-557229
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities138219734-66.3468
    Capital Expenditures-193-405-376-452-105
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items1,058-3970-9.774.59
    Sale of Fixed Assets
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities865-803-376-461-100
    Financing Cash Flow Items-0.14-0.333-0.279——
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-955631-253497-416
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash47.446.6105-31-47.3